Tabar V, Studer L: Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease

Center for Stem Cell Biology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.
Nature (Impact Factor: 41.46). 11/2011; 480(7378):547-51. DOI: 10.1038/nature10648
Source: PubMed


Human pluripotent stem cells (PSCs) are a promising source of cells for applications in regenerative medicine. Directed differentiation of PSCs into specialized cells such as spinal motoneurons or midbrain dopamine (DA) neurons has been achieved. However, the effective use of PSCs for cell therapy has lagged behind. Whereas mouse PSC-derived DA neurons have shown efficacy in models of Parkinson's disease, DA neurons from human PSCs generally show poor in vivo performance. There are also considerable safety concerns for PSCs related to their potential for teratoma formation or neural overgrowth. Here we present a novel floor-plate-based strategy for the derivation of human DA neurons that efficiently engraft in vivo, suggesting that past failures were due to incomplete specification rather than a specific vulnerability of the cells. Midbrain floor-plate precursors are derived from PSCs 11 days after exposure to small molecule activators of sonic hedgehog (SHH) and canonical WNT signalling. Engraftable midbrain DA neurons are obtained by day 25 and can be maintained in vitro for several months. Extensive molecular profiling, biochemical and electrophysiological data define developmental progression and confirm identity of PSC-derived midbrain DA neurons. In vivo survival and function is demonstrated in Parkinson's disease models using three host species. Long-term engraftment in 6-hydroxy-dopamine-lesioned mice and rats demonstrates robust survival of midbrain DA neurons derived from human embryonic stem (ES) cells, complete restoration of amphetamine-induced rotation behaviour and improvements in tests of forelimb use and akinesia. Finally, scalability is demonstrated by transplantation into parkinsonian monkeys. Excellent DA neuron survival, function and lack of neural overgrowth in the three animal models indicate promise for the development of cell-based therapies in Parkinson's disease.

Download full-text


Available from: M. Flint Beal,
  • Source
    • "Interestingly, TFF3 protein was recently detected in various human brain regions, where neurons were identified as the predominant cell type displaying its expression (Bernstein et al., 2015). In addition, Kriks et al. found enhanced TFF3 mRNA levels in human embryonic stem cell cultures directed toward midbrain dopaminergic neurons compared to cultures stimulated to adopt a forebrain identity (Kriks et al., 2011). Thus, most studies on TFFs in the CNS address the distribution of TFF3. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Trefoil factor 1 (TFF1) belongs to a family of secreted peptides that are mainly expressed in the gastrointestinal tract. Notably, TFF1 has been suggested to operate as a neuropeptide, however, its specific cellular expression, regulation and function remain largely unknown. We have previously shown that TFF1 is expressed in developing and adult rat ventral mesencephalic tyrosine hydroxylase-immunoreactive (TH-ir) dopaminergic neurons. Here, we investigated the expression of TFF1 in rat ventral mesencephalic dopaminergic neurons (embryonic day 14) grown in culture for 5, 7 or 10 days in the absence (controls) or presence of either glial cell line-derived neurotrophic factor (GDNF), Forskolin or the combination. No TFF1-ir cells were identified at day 5 and only few at day 7, whereas TH was markedly expressed at both time points. At day 10, several TFF1-ir cells were detected, and their numbers were significantly increased after addition of GDNF (2.2-fold) or Forskolin (4.1-fold) compared to controls. Furthermore, the combination of GDNF and Forskolin had an additive effect and increased the number of TFF1-ir cells by 5.6-fold compared to controls. TFF1 expression was restricted to neuronal cells, and the percentage of TH/TFF1 co-expressing cells was increased to the same extent in GDNF and Forskolin treated cultures (4-fold) as compared to controls. Interestingly, the combination of GDNF and Forskolin resulted in a significantly increased co-expression (8-fold) of TH/TFF1, which could indicate that GDNF and Forskolin targeted different subpopulations of TH/TFF1 neurons. Short-term treatment with Forskolin resulted in an increased number of TFF1-ir cells, and this effect was significantly reduced by the MEK1 inhibitor PD98059 or the PKA inhibitor H89, suggesting that Forskolin induced TFF1 expression through diverse signalling pathways. In conclusion, distinct populations of cultured dopaminergic neurons express TFF1, and their numbers can be increased by factors known to influence survival and differentiation of dopaminergic cells.
    Neuroscience 10/2015; 310. DOI:10.1016/j.neuroscience.2015.10.010 · 3.36 Impact Factor
  • Source
    • "The differentiations into FB, MB and HB were monitored using qRT-PCR, and we confirmed the enrichment of the FACS-isolated populations with a selection of markers previously used to characterize regionalization of differentiated hESCs (Fig. 2C-J) (Kirkeby et al., 2012b). To obtain enriched populations of MB FP progenitors (which do not express SOX1), we added the SHH agonist Purmorphamine (Pur) to the cultures from day 0 to 9 for efficient ventralization of the cells (Kriks et al., 2011). In the presence of Pur, the expression of GFP was heavily decreased in all three conditions (Fig. 2B; supplementary material Fig. S3A-F), and, within the MB and HB cultures, a significant proportion of the cells were identified as CORIN + and FOXA2 + (supplementary material Fig. S3J-Q), consistent with a floor-plate structure in these regions of the embryo (Shimamura et al., 1995). "
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) have been implicated in regulating multiple processes during brain development in various species. However, the function of miRNAs in human brain development remains largely unexplored. Here, we provide a comprehensive analysis of miRNA expression of regionalized neural progenitor cells derived from human embryonic stem cells and human foetal brain. We found miR-92b-3p and miR-130b-5p to be specifically associated with neural progenitors and several miRNAs that display both age-specific and region-specific expression patterns. Among these miRNAs, we identified miR-10 to be specifically expressed in the human hindbrain and spinal cord, while being absent from rostral regions. We found that miR-10 regulates a large number of genes enriched for functions including transcription, actin cytoskeleton and ephrin receptor signalling. When overexpressed, miR-10 influences caudalization of human neural progenitor cells. Together, these data confirm a role for miRNAs in establishing different human neural progenitor populations. This dataset also provides a comprehensive resource for future studies investigating the functional role of different miRNAs in human brain development.
    Development 09/2015; 142(18). DOI:10.1242/dev.122747 · 6.46 Impact Factor
  • Source
    • "For instance, iPSCderived neurons have been shown to match the first trimester stage of human development (Mariani et al., 2012). In the case of midbrain dopamine neurons, a cell type that requires approximately 30 days for cell fate specification, full maturation requires periods of several months to generate functional neurons capable of rescuing dopamine deficits in animal models of PD upon transplantation (Kriks et al., 2011). The process of maturation is distinct from aging and is defined as the gain of full functionality of a given cell or tissue. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In contrast to the successful modeling of early-onset disorders using patient-specific cells, modeling of late-onset neurodegenerative diseases such as Parkinson's disease remains a challenge. This might be related to the often ignored fact that current induced pluripotent stem cell (iPSC) differentiation protocols yield cells that typically show the behavior of fetal stage cells. Acknowledging aging as a contributing factor in late-onset neurodegenerative disorders represents an important step on the road towards faithfully recreating these diseases in vitro. Here, we summarize progress in the field and review the strategies and challenges for triggering late-onset disease phenotypes.
    Development 09/2015; 142(18):3085-3089. DOI:10.1242/dev.120667 · 6.46 Impact Factor
Show more